Measuring prions by bioluminescence imaging

Prions are infectious proteins that cause fatal neurodegenerative diseases. Because astrocytic gliosis marked by the deposition of fibrils composed of GFAP is a prominent feature of prion disease, we asked whether GFAP might be used as a surrogate marker for prions. To interrogate this posit, we inoculated prions into transgenic (Tg) mice expressing luciferase (luc) under the GFAP gene (Gfap) promoter, denoted Tg(Gfap-luc) mice. Weekly noninvasive, bioluminescence imaging (BLI) detected an increase in light emitted from the brains of Tg(Gfap-luc) mice at ≈55 d after inoculation and ≈62 d before neurologic deficits appeared. To determine whether BLI could be used as a proxy bioassay for prion infectivity, we performed endpoint titrations of prions in Tg(Gfap-luc) mice. BLI bioassays were as or more sensitive than those determined by the onset of neurological dysfunction, and were completed in approximately half the time. Our studies argue that BLI is likely to be a suitable surrogate for measuring prion infectivity, and might be useful in the study of Tg mouse models for other neurodegenerative illnesses.

[1]  S. Prusiner,et al.  Regional mapping of prion proteins in brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  S. Prusiner,et al.  Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes , 1993, Cell.

[3]  B. Caughey,et al.  Prions and their partners in crime , 2006, Nature.

[4]  C. Finch,et al.  Glial Fibrillary Acidic Protein: Regulation by Hormones, Cytokines, and Growth Factors , 1994, Brain pathology.

[5]  T. Sklaviadis,et al.  Astrocyte gene expression in Creutzfeldt-Jakob disease. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Stephen J. DeArmond,et al.  Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques , 1989, Cell.

[7]  PierreCordeau,et al.  Live Imaging of Neuroinflammation Reveals Sex and Estrogen Effects on Astrocyte Response to Ischemic Injury , 2008 .

[8]  R. Barlow.  ENCEPHALOPATHY IN MICE PRODUCED BY INOCULATION WITH SCRAPIE BRAIN MATERIAL , 1961 .

[9]  P. Liberski,et al.  Heightened expression of tumor necrosis factor alpha, interleukin 1 alpha, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[10]  I. Campbell,et al.  Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie , 1994, Journal of virology.

[11]  D. Harris,et al.  Successful Transmission of Three Mouse-Adapted Scrapie Strains to Murine Neuroblastoma Cell Lines Overexpressing Wild-Type Mouse Prion Protein , 2000, Journal of Virology.

[12]  A Florence Keller,et al.  Live imaging of amyotrophic lateral sclerosis pathogenesis: Disease onset is characterized by marked induction of GFAP in Schwann cells , 2009, Glia.

[13]  F. Gomes,et al.  Glial fibrillary acidic protein (GFAP): modulation by growth factors and its implication in astrocyte differentiation. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[14]  B. Chesebro.  Introduction to the transmissible spongiform encephalopathies or prion diseases. , 2003, British medical bulletin.

[15]  M. Lovett,et al.  Genetics and polymorphism of the mouse prion gene complex: control of scrapie incubation time , 1988, Molecular and cellular biology.

[16]  S. Prusiner,et al.  Proteinase‐resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity , 1991, Neurology.

[17]  J. de Vellis,et al.  Transition between immature radial glia and mature astrocytes studied with a monoclonal antibody to vimentin. , 1984, Brain research.

[18]  H. Diringer,et al.  ANTIBODIES TO PROTEIN OF SCRAPIE-ASSOCIATED FIBRILS , 1984, The Lancet.

[19]  R. Rodnight,et al.  Age-dependent changes in the regulation by external calcium ions of the phosphorylation of glial fibrillary acidic protein in slices of rat hippocampus. , 1995, Brain research. Developmental brain research.

[20]  P. Cras,et al.  The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease , 2002, Neurobiology of Aging.

[21]  R. Kimberlin,et al.  Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. , 1986, The Journal of general virology.

[22]  M. Otto,et al.  Role of interleukin-1 in prion disease-associated astrocyte activation. , 2004, The American journal of pathology.

[23]  T. Wyss-Coray,et al.  Bioluminescence in vivo imaging of autoimmune encephalomyelitis predicts disease , 2008, Journal of Neuroinflammation.

[24]  R. Kimberlin,et al.  Pathogenesis of Mouse Scrapie: Patterns of Agent Replication in Different Parts of the CNS following Intraperitoneal Infection , 1982, Journal of the Royal Society of Medicine.

[25]  S. Prusiner,et al.  Measurement of the scrapie agent using an incubation time interval assay , 1982, Annals of neurology.

[26]  R. L. Chandler.  ENCEPHALOPATHY IN MICE , 1962 .

[27]  Lingyun Zhu,et al.  Non-invasive imaging of GFAP expression after neuronal damage in mice , 2004, Neuroscience Letters.

[28]  S. Prusiner,et al.  Cultured Cell Sublines Highly Susceptible to Prion Infection , 2000, Journal of Virology.

[29]  S. Prusiner,et al.  Antibodies to a scrapie prion protein , 1984, Nature.

[30]  S. Prusiner,et al.  Identification of a protein that purifies with the scrapie prion. , 1982, Science.

[31]  Charles Weissmann,et al.  The state of the prion , 2004, Nature Reviews Microbiology.

[32]  S. Prusiner.  Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[33]  S. Prusiner,et al.  Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. , 1980, Biochemistry.

[34]  P. Mcgeer,et al.  Glial reactions in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[35]  S. Prusiner,et al.  Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  L. Stoltze,et al.  A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  V. Perry,et al.  Transforming growth factor β1, the dominant cytokine in murine prion disease: influence on inflammatory cytokine synthesis and alteration of vascular extracellular matrix , 2002, Neuropathology and applied neurobiology.

[38]  F. Cohen,et al.  Heritable disorder resembling neuronal storage disease in mice expressing prion protein with deletion of an α-helix , 1997, Nature Medicine.

[39]  Richard C. Moore,et al.  Genes contributing to prion pathogenesis. , 2008, The Journal of general virology.

[40]  S. Prusiner,et al.  Scrapie in mice deficient in apolipoprotein E or glial fibrillary acidic protein , 1996, Neurology.

[41]  E. J. Field.  The significance of astroglial hypertrophy in Scrapie, Kuru, Multiple Sclerosis and old age together with a note on the possible nature of the scrapie agent , 1967, Deutsche Zeitschrift für Nervenheilkunde.

[42]  H. Fraser,et al.  Immunocytochemical appearance of cytokines, prostaglandin E2 and lipocortin-1 in the CNS during the incubation period of murine scrapie correlates with progressive PrP accumulations , 1997, Brain Research.

[43]  Inyoul Y. Lee,et al.  A systems approach to prion disease , 2009, Molecular systems biology.

[44]  Y. Weng,et al.  Live Imaging of Neuroinflammation Reveals Sex and Estrogen Effects on Astrocyte Response to Ischemic Injury , 2008, Stroke.

[45]  Adriano Aguzzi,et al.  Molecular mechanisms of prion pathogenesis. , 2008, Annual review of pathology.

[46]  Kshitij D Modi,et al.  Reduction of Astrogliosis by Early Treatment of Pneumococcal Meningitis Measured by Simultaneous Imaging, In Vivo, of the Pathogen and Host Response , 2005, Infection and Immunity.